List of Tables
Table 1. Therapeutic Peptide Market Trends
Table 2. Therapeutic Peptide Market Drivers & Opportunity
Table 3. Therapeutic Peptide Market Challenges
Table 4. Therapeutic Peptide Market Restraints
Table 5. Global Therapeutic Peptide Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Therapeutic Peptide Revenue Market Share by Company (2019-2024)
Table 7. Global Therapeutic Peptide Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Therapeutic Peptide Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Therapeutic Peptide Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Therapeutic Peptide Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Therapeutic Peptide Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Therapeutic Peptide
Table 13. Global Therapeutic Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Peptide as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Therapeutic Peptide Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Therapeutic Peptide Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Therapeutic Peptide Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Therapeutic Peptide Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Therapeutic Peptide Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Therapeutic Peptide Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Therapeutic Peptide Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Therapeutic Peptide Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Therapeutic Peptide Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Therapeutic Peptide Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Therapeutic Peptide Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Therapeutic Peptide Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Therapeutic Peptide Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Therapeutic Peptide Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Therapeutic Peptide Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Therapeutic Peptide Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Therapeutic Peptide Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Therapeutic Peptide Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Therapeutic Peptide Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Therapeutic Peptide Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Therapeutic Peptide Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Therapeutic Peptide Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Therapeutic Peptide Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Therapeutic Peptide Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Therapeutic Peptide Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Therapeutic Peptide Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Therapeutic Peptide Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Therapeutic Peptide Sales Value by Region (2019-2024) & (%)
Table 44. Global Therapeutic Peptide Sales Value by Region (2025-2030) & (%)
Table 45. Global Therapeutic Peptide Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Therapeutic Peptide Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Therapeutic Peptide Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Therapeutic Peptide Sales Volume by Region (2019-2024) & (%)
Table 49. Global Therapeutic Peptide Sales Volume by Region (2025-2030) & (%)
Table 50. Global Therapeutic Peptide Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Therapeutic Peptide Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Therapeutic Peptide Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Therapeutic Peptide Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Therapeutic Peptide Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Therapeutic Peptide Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Therapeutic Peptide Sales Volume, (2025-2030) & (K Units)
Table 57. AbbVie Company Information
Table 58. AbbVie Introduction and Business Overview
Table 59. AbbVie Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. AbbVie Therapeutic Peptide Product Offerings
Table 61. AbbVie Recent Development
Table 62. AstraZeneca Company Information
Table 63. AstraZeneca Introduction and Business Overview
Table 64. AstraZeneca Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. AstraZeneca Therapeutic Peptide Product Offerings
Table 66. AstraZeneca Recent Development
Table 67. Ipsen Company Information
Table 68. Ipsen Introduction and Business Overview
Table 69. Ipsen Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Ipsen Therapeutic Peptide Product Offerings
Table 71. Ipsen Recent Development
Table 72. Eli Lilly Company Information
Table 73. Eli Lilly Introduction and Business Overview
Table 74. Eli Lilly Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Eli Lilly Therapeutic Peptide Product Offerings
Table 76. Eli Lilly Recent Development
Table 77. Merck Company Information
Table 78. Merck Introduction and Business Overview
Table 79. Merck Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Merck Therapeutic Peptide Product Offerings
Table 81. Merck Recent Development
Table 82. Novo Nordisk Company Information
Table 83. Novo Nordisk Introduction and Business Overview
Table 84. Novo Nordisk Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Novo Nordisk Therapeutic Peptide Product Offerings
Table 86. Novo Nordisk Recent Development
Table 87. Novartis Company Information
Table 88. Novartis Introduction and Business Overview
Table 89. Novartis Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Novartis Therapeutic Peptide Product Offerings
Table 91. Novartis Recent Development
Table 92. Johnson and Johnson Company Information
Table 93. Johnson and Johnson Introduction and Business Overview
Table 94. Johnson and Johnson Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Johnson and Johnson Therapeutic Peptide Product Offerings
Table 96. Johnson and Johnson Recent Development
Table 97. Sanofi Company Information
Table 98. Sanofi Introduction and Business Overview
Table 99. Sanofi Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Sanofi Therapeutic Peptide Product Offerings
Table 101. Sanofi Recent Development
Table 102. Teva Company Information
Table 103. Teva Introduction and Business Overview
Table 104. Teva Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Teva Therapeutic Peptide Product Offerings
Table 106. Teva Recent Development
Table 107. Takeda Company Information
Table 108. Takeda Introduction and Business Overview
Table 109. Takeda Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Takeda Therapeutic Peptide Product Offerings
Table 111. Takeda Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Therapeutic Peptide Downstream Customers
Table 115. Therapeutic Peptide Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Peptide Product Picture
Figure 2. Global Therapeutic Peptide Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Therapeutic Peptide Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Therapeutic Peptide Sales Volume (2019-2030) & (K Units)
Figure 5. Global Therapeutic Peptide Sales Price (2019-2030) & (US$/Unit)
Figure 6. Therapeutic Peptide Report Years Considered
Figure 7. Global Therapeutic Peptide Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Therapeutic Peptide Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Therapeutic Peptide Revenue in 2023
Figure 10. Therapeutic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Picture
Figure 12. Injection Picture
Figure 13. Other Picture
Figure 14. Global Therapeutic Peptide Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Therapeutic Peptide Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Therapeutic Peptide Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Therapeutic Peptide Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Therapeutic Peptide Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Cancer
Figure 20. Product Picture of Metabolic Disorders
Figure 21. Product Picture of Central Nervous System
Figure 22. Product Picture of Other
Figure 23. Global Therapeutic Peptide Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Therapeutic Peptide Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Therapeutic Peptide Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Therapeutic Peptide Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Therapeutic Peptide Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Therapeutic Peptide Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Therapeutic Peptide Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Therapeutic Peptide Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Therapeutic Peptide Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Therapeutic Peptide Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Therapeutic Peptide Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Therapeutic Peptide Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Therapeutic Peptide Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Therapeutic Peptide Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Therapeutic Peptide Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Therapeutic Peptide Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Therapeutic Peptide Sales Volume (%), (2019-2030)
Figure 40. United States Therapeutic Peptide Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Therapeutic Peptide Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Therapeutic Peptide Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Therapeutic Peptide Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Therapeutic Peptide Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Therapeutic Peptide Sales Value by Application (%), 2023 VS 2030
Figure 46. China Therapeutic Peptide Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Therapeutic Peptide Sales Value by Type (%), 2023 VS 2030
Figure 48. China Therapeutic Peptide Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Therapeutic Peptide Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Therapeutic Peptide Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Therapeutic Peptide Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Therapeutic Peptide Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Therapeutic Peptide Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Therapeutic Peptide Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Therapeutic Peptide Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Therapeutic Peptide Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Therapeutic Peptide Sales Value by Application (%), 2023 VS 2030
Figure 58. India Therapeutic Peptide Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Therapeutic Peptide Sales Value by Type (%), 2023 VS 2030
Figure 60. India Therapeutic Peptide Sales Value by Application (%), 2023 VS 2030
Figure 61. Therapeutic Peptide Industrial Chain
Figure 62. Therapeutic Peptide Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
